bioRxivMicrobiology
Early Emergence and Long-Term Persistence of HIV-Infected T Cell Clones in Children
M. J. Bale, M. G. Katusiime, D. Wells, X. Wu, J. Spindler, E. K. Halvas, J. C. Cyktor, A. Wiegand, W. Shao, M. F. Cotton, S. H. Hughes, J. W. Mellors, J. M. Coffin, G. U. Van Zyl, M. F. Kearney
Abstract
Little is known about the emergence and persistence of HIV-infected T cell clones in perinatally-infected children. We analyzed peripheral blood mononuclear cells for clonal expansion in 11 children who initiated antiretroviral therapy (ART) between 1.8-17.4 months of age and with viremia suppressed for 6-9 years. We obtained 8,662 HIV-1 integration sites from pre-ART and 1,861 sites on ART. Expanded clones of infected cells were detected pre-ART in 10/11 children. In 8 children, infected cell clones detected pre-ART persisted for 6-9 years on ART. A comparison of integration sites in the samples obtained on ART with healthy donor PBMC infected ex-vivo showed selection for cells with proviruses integrated in BACH2 and STAT5B. Our analyses indicate that, despite marked differences in T cell composition and dynamics between children and adults, HIV-infected cell clones are established early in children, persist for up to 9 years on ART, and can be driven by proviral integration in proto-oncogenes.
- organism: human
- assay: DNA methylation
- research focus: cell type annotation
- research focus: clustering
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Distinct immune profiles in children living with HIV based on timing and duration of suppressive antiretroviral treatment
Madeline J. Lee, Morgan L. Litchford, … Catherine A. Blish·VirologyPeer-reviewed·Nov 26, 2024
- A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation
D. B. Reeves, E. R. Duke, … J. T. Schiffer·bioRxiv·Sep 7, 2018
- Integration in or Near Oncogenes Plays Only a Minor Role in Determining the in Vivo Distribution of HIV Integration Sites Before or During Suppressive Antiretroviral Therapy
J. M. Coffin, M. Bale, … S. H. Hughes·bioRxiv·Nov 25, 2020
- Antigen-driven clonal selection shapes the persistence of HIV-1 infected CD4+ T cells in vivo
F. R. Simonetti, H. Zhang, … R. F. Siliciano·bioRxiv·Dec 1, 2020
- Determinants of precocious B-cell aging in European adolescences living with perinatally acquired HIV-1 after over 10 years of suppressive therapy
A. Ruggiero, G. R. Pascucci, … included in the manuscript·bioRxiv·Nov 11, 2021
- Single-cell immune profiling reveals the impact of antiretroviral therapy on HIV-1-induced immune dysfunction, T cell clonal expansion, and HIV-1 persistence in vivo
J. A. Collora, D. Pinto-Santini, … Y.-C. Ho·bioRxiv·Jan 27, 2021